Hypertension is a leading modifiable risk factor for cardiovascular disease and premature death worldwide. Despite available pharmacological treatments, poor adherence to anti-hypertensive medication remains a major obstacle to blood pressure control, with reported non-adherence rates of 45–65% in sub-Saharan Africa. In Zambia, uncontrolled hypertension contributes substantially to hospital morbidity and mortality, yet local, context-specific data on adherence determinants are limited. This study evaluated factors associated with adherence among patients attending Railway Surgery Urban Health Centre in Ndola, Zambia.
A cross-sectional design was used. The study enrolled 237 hypertensive patients presenting to the Railway Surgery Urban Health Centre in Ndola. Data collection employed a structured, interviewer-administered questionnaire capturing socio-demographic characteristics, clinical factors, and medication adherence measured with the modified Hill-Bone Compliance Scale. Analytical approaches included descriptive statistics, chi-square tests for bivariate associations, and multivariable logistic regression to identify independent predictors. Statistical significance was set at p<0.05. The maximum possible adherence score on the scale was 32.
Adherence and overall scores
Overall adherence was suboptimal: 41.4% of participants were classified as adherent, while 58.6% were non-adherent. The cohort’s mean adherence score was 19.8 (SD = 4.6) out of a possible 32.
Reported reasons for non-adherence
The most commonly reported reasons for missing medication were running out of pills (mean item score = 2.6), being away from home (mean = 2.5), and forgetting to take medication (mean = 2.4).
Socio-demographic associations
Age, education, and income were significantly associated with adherence in bivariate analyses: age (p = 0.006), education level (p = 0.001), and monthly income (p = 0.001).
Clinical associations
Clinical factors linked with poorer adherence included the presence of comorbidities (p = 0.027), experiencing medication side effects (p < 0.001), and greater medication regimen complexity (p = 0.007).
Health service experience and appointment data
Participants reported a range of service-level challenges. Transport-related missed appointments occurred in 35.4% of respondents. Medication stock-outs were reported by 38.4% of participants. Counselling time was frequently brief: 49.8% of patients reported receiving under five minutes of counselling at the facility.
Participants described multiple system-level obstacles that likely contributed to non-adherence. Long distances to the facility and reliance on public transport were noted as practical barriers to maintaining treatment and attending appointments. Medication supply interruptions were common, with 38.4% reporting stock-outs. Brief counselling interactions at the health centre—under five minutes for nearly half of patients—may have limited opportunities for education about dosing, side-effect management, and refill planning.
In multivariable logistic regression, several factors were independently associated with adherence. Older age (≥51 years), higher education (secondary/tertiary), and higher monthly income (≥K1,000) were associated with greater odds of adherence. Conversely, presence of comorbidities, experiencing side effects, and more complex medication regimens were independently associated with lower adherence. Adjusted odds ratios and confidence intervals were reported in the original analysis.
Adherence to anti-hypertensive medication at the Railway Surgery Urban Health Centre in Ndola is suboptimal, with 58.6% of patients classified as non-adherent and a mean adherence score below the maximum. The study identifies a combination of socio-demographic, clinical, and health system factors linked to non-adherence. Key patient-level contributors include younger age, lower education and income, comorbidities, side effects, and regimen complexity. System-level contributors include transport challenges, medication stock-outs, and brief counselling.
Recommended programmatic responses include:
These targeted actions aim to improve blood pressure control and reduce hypertension-related morbidity and mortality in this setting.
The study received ethical approval from the Chreso University Research Ethics Committee. The authors declared no competing interests. All study data are available from the authors upon reasonable request, as noted in the source report.